Innovation at Penn
Browse Penn-owned technologies available for licensing.
Search Results - martin carroll
Expedited Assay and Analysis to Determine Acute Myeloid Leukemia Patient Prognosis
mia (AML) is the most common acute leukemia in adults and affects 12.2 per 100,000 people older than 65 years old. Only 50-80% of patients reach complete remission (CR) as a result of standard chemotherapy while the rest suffer from side effects without significant benefit to their health. Variable response to chemotherapy in AML represents a major...
Research Tools & Reagents
© 2020. All Rights Reserved. Powered by